Meloxicam

QAMZOVA, XIFYRM, Zybic

Nonsteroidal Anti-inflammatory Drug

NADAC/unit $0.0164

No Shortage Tier 1: 187.2% 13 Manufacturers 28 ANDAs

Meloxicam reduces pain, inflammation, and fever by inhibiting prostaglandin synthesis.

vs. brand QAMZOVA: Generic saves up to 100% per unit

Covered Lives

Market Intelligence

2024-01-03 Class II Recall: CARDINAL HEALTHCARE

Generic Manufacturers

AIPING PHARMACEUTICAL INCASCENT PHARMACEUTICALS INCAUROBINDO PHARMA LTDAVONDALE PHARMACEUTICALS LLCAZURITY PHARMACEUTICALS INCCIPLA LTDCOREPHARMA LLCGLENMARK PHARMACEUTICALS LTDLUPIN LTDNANJING DELOVA BIOTECH CO LTDNOVITIUM PHARMA LLCPURACAP PHARMACEUTICAL LLCRISING PHARMA HOLDINGS INCUNICHEM LABORATORIES LTDYUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTDZYDUS PHARMACEUTICALS USA INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Meloxicam drfinder.aiFind doctors who prescribe Meloxicam jointpain.aiLearn about joint pain relief rxnews.aiLatest news about Meloxicam

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.